ESC Professional Premium Access

Stroke prevention by anticoagulation and appendage occlusion in atrial fibrillation

Event: ESC Congress 2022
Topic: Treatment
Session type: Moderated ePosters
Date: 27 August 2022
Time: 15:15 - 15:45

Congress Session

5 presentations in this session

Risk of stroke and transient ischemic attack after elective cardioversion of atrial fibrillation: A nationwide study in Finland

Speaker: Mrs S. Itainen-Stromberg (Helsinki, FI)

Clinical risk prediction for left atrial appendage thrombus among patients with atrial fibrillation

Speaker: Professor P. Kistler (Melbourne, AU)

Left atrial appendage occlusion versus standard of care in patients with atrial fibrillation and a prior thrombo-embolic event despite oral anticoagulant therapy: a propensity score matched comparison

Speaker: Professor L. Boersma (Nieuwegein, NL)

Decreased device related thrombus and enhanced neo-endocardial tissue maturation with a new generation left atrial appendage closure (LAAC) device. An anticoagulation and antiplatelet free canin study

Speaker: Professor W. Saliba (Cleveland, US)

Impact of ABC pathway adherence in high-risk patients with atrial fibrillation: an analysis from the ESC-EHRA EORP-AF long-term general registry

Speaker: Doctor W. Ding (Liverpool, GB)

5 speakers from this session

Mrs Saga Itainen-Stromberg

Helsinki University Hospital, Helsinki (Finland)
0 follower

Professor Peter Kistler

The Alfred Hospital, Melbourne (Australia)
1 presentation
0 follower

Professor Lucas Boersma

St Antonius Hospital, Nieuwegein (Netherlands (The))
22 presentations
1 follower

Professor Walid Saliba

Cleveland Clinic Foundation, Cleveland (United States of America)
0 follower

Doctor Wern Yew Ding

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
0 follower

This platform is supported by

logo Novo Nordisk